Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial

NCT03080493 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT03080493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03080493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial
Lead sponsor
University of California, Davis
Phase
Phase 4
Overall status
Completed
Start date
March 20, 2017
Completion date
November 5, 2018
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion, induced, cervical preparation, pain